var data={"title":"Gallium citrate Ga-67: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Gallium citrate Ga-67: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/147247?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=gallium-citrate-ga-67-patient-drug-information\" class=\"drug drug_patient\">see &quot;Gallium citrate Ga-67: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176404\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Radiopharmaceutical</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176473\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Diagnostic imaging:</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Manufacturer's labeling:  (based on 70 kg patient): 2 to 5 mCi (74 to 185 MBq).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Alternative dosing:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Scintigraphy for inflammation or infection: 4 to 6 mCi (150 to 220 MBq) (ACR/SPR 2014)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tumor scintigraphy: 5 to 10 mCi (185 to 370 MBq) (ACR/SPR 2015)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176472\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Diagnostic imaging:</b> Scintigraphy for inflammation or infection (off-label use): IV: 0.07 mCi/kg (2.6 MBq/kg), with a minimum of 0.5 mCi (18.5 MBq) (ACR/SPR 2014) <b>or</b> alternatively for children &gt;5 years: 0.04 to 0.07 mCi/kg (1.5 to 2.6 MBq/kg) (Palestro 2004)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15896332\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15896333\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20217923\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">IV: For IV administration. Radiopharmaceutical; use appropriate precautions for handling and disposal. Use waterproof gloves and effective radiation shielding when handling.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">The manufacturer recommends administration of daily laxatives and/or enemas from the day of injection until final images are obtained to cleanse the bowel of radioactive material and to minimize false positive results.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176405\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Diagnostic imaging:</b> Diagnostic imaging agent for use in identifying the presence and extent of Hodgkin disease, lymphoma, bronchogenic carcinoma, and acute inflammatory lesions </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13255250\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Gallium Citrate Ga-67 may be confused with Gallium Ga 68 Dotatate</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176476\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Rash</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Nausea</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Miscellaneous: Hypersensitivity reactions</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25593625\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;\">There are no contraindications listed in the manufacturer&rsquo;s labeling. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176406\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special handling: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and health care personnel. Use only under supervision of individuals with experience/training in the handling of radioactive materials approved by the applicable regulatory authority.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other Warnings/Precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: The finding of an abnormal gallium Ga-67 concentration usually implies the existence of underlying pathology, but further diagnostic studies should be done to distinguish benign from malignant lesions. Use is intended as an adjunct in the diagnosis of certain neoplasms as well as focal areas of infection. Certain pathologic conditions may yield up to 40% false-negative gallium Ga-67 studies; a negative study cannot be definitely interpreted as ruling out the presence of disease. Lymphocytic lymphoma frequently does not accumulate gallium Ga-67 sufficiently for unequivocal imaging, and the use of gallium with this histologic type of lymphoma is not recommended at this time. Gallium Ga-67 localization cannot differentiate between tumor and acute inflammation, and other diagnostic studies must be added to define the underlying pathology.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP 1997; CDC 1982); some data suggest that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer&rsquo;s labeling. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176452\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176453\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Ga 67 can accumulate in the placenta (Kurosak 2001; Newman 1978; Palestro 1986). The manufacturer recommends that when elective procedures are conducted in women of reproductive potential, they should be done within the first 10 days of menses.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13176455\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Ga 67 accumulates in the breast even in nonlactating patients (Hor 1976). Significant concentrations were detected in the breast milk of one postpartum woman 10 days after dosing (Hoffer 1977). The actual concentration may depend on volume of milk flow and stage of breast-feeding (Tobin 1976). The manufacturer recommends to substitute formula for breast milk. Due to the long half-life of Ga 67, one guideline recommends discontinuing breast-feeding for at least 2 to 4 weeks after the injection in order to reduce exposure to the breast-feeding infant (Palestro 2004). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46023658\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Gallium citrate Ga-67 is a radioactive diagnostic agent which accumulates in lysosomes and is bound to a soluble intracellular protein. It has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infections.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46023659\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: Physical: 78.26 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: After 7 days: Average whole body retention 65%, urine 26%, feces 9%</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American College of Radiology, Society for Pediatric Radiology. ACR-SPR Practice Parameter for the Performance of Scintigraphy for Inflammation and Infection. Resolution 31. http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Infections_Inflammation.pdf. Revised 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American College of Radiology, Society for Pediatric Radiology. ACR-SPR Practice Parameter for the Performance of Tumor Scintigraphy (With Gamma Cameras). Resolution 48. http://www.acr.org/~/media/921761B083FE4457A9121953D080BA1C.pdf. Revised 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol--United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291.  <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gallium Citrate Ga 67 [prescribing information]. Maryland Heights, MO: Mallinckrodt Nuclear Medicine LLC; October 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs. <i>Pediatrics</i>.1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hoffer PB, Huberty J, Khayam-Bashi H. The association of Ga-67 and lactoferrin. <i>J Nucl Med</i>. 1977;18(7):713-717. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/267143/pubmed\" target=\"_blank\" id=\"267143\">267143</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    H&ouml;r G, Heidenreich P, Kriegel H, et al. Letter: Breast scintigraphy with 99mTc-pertechnetate and 67Ga-citrate. <i>J Nucl Med</i>. 1976;17(3):223.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/1249634/pubmed\" target=\"_blank\" id=\"1249634\">1249634</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kurosaki H, Saito Y, Kawashima M, et al. Accumulation of 67Ga citrate in early pregnancy. <i>Ann Nucl Med</i>. 2001;15(3):289-291.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/11545204/pubmed\" target=\"_blank\" id=\"11545204\">11545204</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Newman RA, Gallagher JG, Clements JP, et al. Demonstration of Ga-67 localization in human placenta. <i>J Nucl Med</i>. 1978;19(5):504-506. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/580436/pubmed\" target=\"_blank\" id=\"580436\">580436</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Palestro CJ, Brown ML, Forstrom LA, et al, &ldquo;Society of Nuclear Medicine Procedure Guideline for Gallium Scintigraphy in Inflammation,&quot; 2004. Available at http://interactive.snm.org/docs/Gallium_Scintigraphy_in_Inflammation_v3.pdf</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Palestro CJ, Malat J, Collica CJ, et al. Incidental diagnosis of pregnancy on bone and gallium scintigraphy. <i>J Nucl Med</i>. 1986;27(3):370-372.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/2940348/pubmed\" target=\"_blank\" id=\"2940348\">2940348</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tobin RE, Schneider PB. Uptake of 67Ga in the lactating breast and its persistence in milk: case report. <i>J Nucl Med</i>. 1976;17(12):1055-1056. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/gallium-citrate-ga-67-drug-information/abstract-text/993836/pubmed\" target=\"_blank\" id=\"993836\">993836</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 16796 Version 37.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F13176404\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F13176473\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F13176472\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F15896332\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F15896333\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F20217923\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F13176405\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F13255250\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F13176476\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F25593625\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F13176406\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F13176452\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13176453\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F13176455\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F46023658\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F46023659\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/16796|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=gallium-citrate-ga-67-patient-drug-information\" class=\"drug drug_patient\">Gallium citrate Ga-67: Patient drug information</a></li></ul></div></div>","javascript":null}